Legend Biotech Corp. reported a robust performance for Q4 2024, driven by a significant increase in CARVICTI sales. The company achieved net sales of $334 million for CARVICTI, marking a 110% ...

Legend Power Systems, with a market capitalization of $19 million, reported significant growth in its first-quarter earnings, marking a notable improvement in financial performance. The company ...

Good day, ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Legend Biotech Corp (LEGN) reported its second-quarter earnings for 2025, revealing a significant increase in revenue but a larger-than-expected loss per share. The company’s revenue reached 255.06 ...

Legend Biotech Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to Legend Biotech Reports ...

Ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech Second Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded. I ...

MS. TUMULTY: Hello, and welcome to Washington Post Live. I’m Karen Tumulty, a columnist and associate editor here at The Post, and it’s my great honor today to welcome my colleague, Max Boot, to talk ...